Privia Health Group, Inc. (PRVA) Tops Q4 EPS by 11c, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Privia Health Group Inc (PRVA) PT Lowered to $28 at Truist Securities
February 29, 2024 5:50 AM ESTTruist Securities analyst Jailendra Singh lowered the price target on Privia Health Group Inc (NASDAQ: PRVA) to $28.00 (from $32.00) while maintaining a Buy rating.
The analyst comments "We had a post quarterly conference call with PRVA management to discuss its 4Q23 results, 2024... More
JPMorgan Positive on Privia Health Group Inc (PRVA) Following Earnings, Management Call
February 27, 2024 12:09 PM ESTJPMorgan analyst Lisa C. Gill reiterated an Overweight rating and $20.00 price target on Privia Health Group Inc (NASDAQ: PRVA)
The analyst comments "We are positive on PRVA as the companys notably more conservative and contrarian approach to capitated risk is driving greater financial... More
